Erin Hunter is an assistant editor at Pharmacy Times®. She is a proud alumna of the University of Massachusetts. She graduated with degrees in Journalism, Art History, and Environmental Conservation.
Ultra-Processed Foods Found to Increase Colorectal Cancer Risk in Men
Study indicates that a diet high in ultra-processed food is more likely to increase the risk of colorectal cancer in men than it is women.
Study: Medical Cannabis May Have Far-Reaching Benefits for Neurological Disorders
Research suggests cannabis can improve quality of life for patients who suffer from pain and neurological disorders.
Glaucoma Treatment Shows Positive Results in Phase 3 Trial
Researchers will submit a new drug application to the FDA after a phase 3 trial found that iDose TR slow- and fast-release models met their primary endpoint in patients with glaucoma.
Nasal Self-Sampling Rapid Antigen COVID-19 Test Performance May Have Decreased Over Time
While the performance of nasal self-sampling rapid antigen tests for COVID-19 was found to decrease over time, adding oropharyngeal may improve its performance.
Low Testosterone in Men May be a Risk Factor for Hospitalization from COVID-19
Men with chronically low testosterone levels are more likely to be hospitalized from COVID-19 than those with normal levels, but testosterone therapy could decrease this risk.
Study: Online Communities Can Provide Lifeline for Patients in Remission from Opioid Use Disorder
Online communities can help opioid users in remission maintain long-lasting sobriety, however the research suggests these communities should be non-drug-related.
Study: Geographical Location May Be Associated With Certain Risk Factors, Cancer Mortality
Researchers found differences in the variable importance of cancer mortality risk factors depending on an individual’s geographical region.
FDA Approves Terlipressin to Improve Kidney Function in Hepatorenal Syndrome
The drug improves kidney function in adults with hepatorenal syndrome with rapid reduction in kidney function.
Onset of Type 2 Diabetes in Adults Aged 40 or Younger Increases Risk of Cardiovascular Disease
Researchers found that patients diagnosed with early-onset type 2 diabetes have a greater risk of premature death than the general population.
Anti-Malaria Drug Hydroquinine May Effectively Treat Drug-Resistant Bacteria
Researchers have identified hydroquinine as a potential treatment against drug-resistant bacteria, which can cause infections with a 70% mortality rate.
Gene Therapy Restores Some Vision in Colorblind Children
Study suggests gene therapy may effectively treat young children who were born colorblind via pathways connecting the brain and the retina.
Subcutaneous Insulin Aspart May be Cost-effective Treatment for Mild Diabetic Ketoacidosis in Children
Research suggests that subcutaneous insulin aspart is a cost-effective and accessible treatment option that could allow children with type 1 diabetes to avoid the ICU after a mild episode of diabetic ketoacidosis.
Study: Fianlimab With Cemiplimab Combination Shows High Response Rate in Certain Patients With Advanced Melanoma
New research presented at ESMO Congress found that certain patients with advanced melanoma administered a combination of cemiplimab with fianlimab experienced a median progression-free survival of 2 years.
Study: Consistent Consumption of Alcohol May Increase Risk Of Atrial Fibrillation in Young Adults
Excess drinking is a major atrial fibrillation risk factor in young people.
Osimertinib Significantly Improves Disease-Free Survival in EGFR-Mutated Lung Cancer
Researchers at the European Society for Medical Oncology Congress presented findings that show osimertinib may clinically reduce the risk of lung cancer recurrence.
Clovis Oncology Submits New Drug Application for Rucaparib as First-Line Maintenance Treatment for Advanced Ovarian Cancer
Research suggests that rucaparib can increase progression-free survival by more than a year in women with advanced ovarian cancer.
FDA Accepts New Drug Application for Aripiprazole Long-Acting Injectable for Schizophrenia, Bipolar Disorder
The New Drug Application for aripiprazole 2-month, ready-to-use, long-acting injectable could lead to the first FDA approval of a 2-month schizophrenia and bipolar I disorder antipsychotic treatment.
Lesser Known Complications Hospitalizing More Patients With Type 2 Diabetes
Research suggests that non-traditional complications from type 2 diabetes are hospitalizing more people now than they did 20 years ago.
Ribociclib Can Add Almost 1 Year to Overall Survival for Patients With Aggressive Form of Breast Cancer
Ribociclib with endocrine therapy was found to increase the median overall survival of patients with HR+/HER2- advanced breast cancer with visceral metastases to nearly 5 years.
Sotorasib Significantly Improves Progression-Free Survival for KRAS G12C-Mutated Non-Small Cell Lung Cancer in Phase 3 Trial
Data presented at the European Society for Medical Oncology Congress showed that sotorasib increased progression-free survival to 1 year in 25% of patients with KRAS G12C-mutated non-small cell lung cancer.
Phase 3 Trial Launches for Acute Migraine Treatment
Surveys show that 70% of migraine sufferers are not satisfied with their current acute treatment regimen.
Study: Anti-Depressants May Help Avoid Severe COVID-19 Symptoms
Although serotonin is widely associated with feelings of happiness, a study suggests it may be associated with the severity of COVID-19.
Study: Refundable State-Level Earned Income Tax Credit Could Decrease High-Risk HIV Behavior
A refundable state-level earned income tax credit was associated with a 21% reduction in high-risk HIV behavior among low-income women last year, suggesting that policy can reduce this burden.
Study: Olokinzumab As Effective as “Gold Standard” Treatment for Rheumatoid Arthritis
Researchers expect to file for FDA approval within the year following the successful phase 3 trial.
Study: Three COVID-19 Vaccine Doses May Provide Better, Longer Protection Than Two
Receiving 3 doses of the COVID-19 vaccine can offer better and more long-lasting protection against the Omicron variant.
Fruquintinib Meets Primary Endpoint of Overall Survival for Metastatic Colorectal Cancer
Fruquintinib reduced the risk of death in patients with advanced metastatic colorectal cancer by 34% and led to longer overall survival than among those given placebo.
Antigen Biomarkers Could Predict Disease Progression of Hospitalized COVID-19 Patients
Viral antigen levels in blood plasma can provide clinically important patient outcomes among hospitalized patients with COVID-19.
Study: Programs to Limit Prescription Opioids May Spur Illegal Drug Use
Prescription drug monitoring programs have decreased prescription opioids in the United States but resulted in unintended spikes of illegal drug use and heroin-related deaths.
Study: COVID-19 Vaccine Prevented Approximately 27 Million Infections in US Adults
The percentage of infections, hospitalizations, and deaths that were prevented from COVID-19 vaccination increased with greater vaccine coverage, according to a recent study.
Study: Young Children Previously Infected With COVID-19 May Have Long-term Immune Response
Children younger than age 6 years might be protected from other COVID-19 variants for up to a year after infection.
2 Clarke Drive Cranbury, NJ 08512